Chemosensitization of Plasmodium falciparum by probenecid in vitro

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 7, 2003, Pages 2108-2112

  Nzila, Alexis ^a   Mberu, Eddy ^a   Bray, Pat ^b   Kokwaro, Gilbert ^a   Winstanley, Peter ^a   Marsh, Kevin ^c,d   Ward, Steve ^b  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORCYCLOGUANIL; CHLOROQUINE; DAPSONE; FANSIDAR; FOLIC ACID; FOLIC ACID ANTAGONIST; METHOTREXATE; PROBENECID; PYRIMETHAMINE; SULFADOXINE;

ARTICLE; CHEMOSENSITIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG TRANSPORT; DRUG UPTAKE; IN VITRO STUDY; ISOTOPE LABELING; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTIMALARIALS; DAPSONE; DRUG RESISTANCE; PLASMODIUM FALCIPARUM; PROBENECID; SULFADOXINE; URICOSURIC AGENTS;

EID: 0038676970     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.7.2108-2112.2003     Document Type: Article

References (46)

1. Antony, A. C. 1996. Folate receptors. Annu. Rev. Nutr. 16:501-521.
2. Banerjee, D., P. Mayer-Kuckuk, G. Capiaux, T. Budak-Alpdogan, R. Gorlick, and J. R. Bertino. 2002. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim. Biophys. Acta 1587:164-173.
3. Bertino, J. R. 1993. Karnofsky Memorial Lecture. Ode to methotrexate. J. Clin. Oncol. 11:5-14.
4. Borst, P., R. Evers, M. Kool, and J. Wijnholds. 2000. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92:1295-1302.
5. Borst, P., R. Evers, M. Kool, and J. Wijnholds. 1999. The multidrug resistance protein family. Biochim. Biophys. Acta 1461:347-357.
6. Bray, P. G., O. Janneh, K. J. Raynes, M. Mungthin, H. Ginsburg, and S. A. Ward. 1999. Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum. J. Cell Biol. 145:363-376.
7. Cunningham, R. F., Z. H. Israili, and P. G. Dayton. 1981. Clinical pharmacokinetics of probenecid. Clin. Pharmacokinet. 6:135-151.
8. Desai, S. A., S. M. Bezrukov, and J. Zimmerberg. 2000. A voltage-dependent channel involved in nutrient uptake by red blood cells infected with the malaria parasite. Nature 406:1001-1005.
9. Djimde, A., O. K. Doumbo, J. F. Cortese, K. Kayentao, S. Doumbo, Y. Diourte, A. Dicko, X. Z. Su, T. Nomura, D. A. Fidock, T. E. Wellems, C. V. Plowe, and D. Coulibaly. 2001. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344:257-263.
10. Fidock, D. A., and T. E. Wellems. 1997. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc. Natl. Acad. Sci. USA 94:10931-10936.
11. Hooijberg, J. H., H. J. Broxterman, M. Kool, Y. G. Assaraf, G. J. Peters, P. Noordhuis, R. J. Scheper, P. Borst, H. M. Pinedo, and G. Jansen. 1999. Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res. 59:2532-2535.
12. Kinyanjui, S. M., E. K. Mberu, P. A. Winstanley, D. P. Jacobus, and W. M. Watkins. 1999. The antimalarial triazine WR99210 and the prodrug PS-15: folate reversal of in vitro activity against Plasmodium falciparum and a non-antifolate mode of action of the prodrug. Am. J. Trop. Med. Hyg. 60:943-947.
13. Matherly, L. H. 2001. Molecular and cellular biology of the human reduced folate carrier. Prog. Nucleic Acids Res. Mol. Biol. 67:131-162.
14. Mutabingwa, T., A. Nzila, E. Mberu, E. Nduati, P. Winstanley, E. Hills, and W. Watkins. 2001. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 358:1218-1223.
15. Nguyen-Dinh, P., H. C. Spencer, S. Chemangey-Masaba, and F. C. Churchill. 1982. Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya. Lancet i:823-825.
16. Nuwaha, F. 2001. The challenge of chloroquine-resistant malaria in subSaharan Africa. Health Policy Plan. 16:1-12.
17. Nzila, A. M., E. K. Mberu, J. Sulo, H. Dayo, P. A. Winstanley, C. H. Sibley, and W. M. Watkins. 2000. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites. Antimicrob. Agents Chemother. 44:991-996.
18. Okelo, G. B. 1984. A review of chloroquine resistance by Plasmodium falciparum in Kenya. East Afr. Med. J. 61:150-153.
19. Oloo, A. J. 1991. Sensitivity of falciparum malaria to chloroquine and amodiaquine in four districts of western Kenya (1985-1987). East Afr. Med. J. 68:606-610.
20. Omar, S. A., I. S. Adagu, D. W. Gump, N. P. Ndaru, and D. C. Warhurst. 2001. Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area. Ann. Trop. Med. Parasitol. 95:661-669.
21. Saliba, K. J., and K. Kirk. 2001. Nutrient acquisition by intracellular apicomplexan parasites: staying in for dinner. Int. J. Parasitol. 31:1321-1330.
22. Sekine, T., S. H. Cha, and H. Endou. 2000. The multispecific organic anion transporter (OAT) family. Pflugers Arch. 440:337-350.
23. Sibley, C. H., J. E. Hyde, P. F. Sims, C. V. Plowe, J. G. Kublin, E. K. Mberu, A. F. Cowman, P. A. Winstanley, W. M. Watkins, and A. M. Nzila. 2001. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17:582-588.
24. Sierra, E. E., and I. D. Goldman. 1999. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates. Semin. Oncol. 26:11-23.
25. Sirotnak, F. M., D. M. Moccio, and C. W. Young. 1981. Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux. Cancer Res. 41:966-970.
26. Sirotnak, F. M., and B. Tolner. 1999. Carrier-mediated membrane transport of folates in mammalian cells. Annu. Rev. Nutr. 19:91-122.
27. Sirotnak, F. M., H. G. Wendel, W. G. Bornmann, W. P. Tong, V. A. Miller, H. I. Scher, and M. G. Kris. 2000. Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo. Clin. Cancer Res. 6:3705-3712.
28. Sixsmith, D. G., W. M. Watkins, J. D. Chulay, and H. C. Spencer. 1984. In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors. Am. J. Trop. Med. Hyg. 33:772-776.
29. Spencer, H. C., W. W. Watkins, D. G. Sixsmith, and D. K. Koech. 1986. Response of Plasmodium falciparum to dihydrofolate reductase inhibitors in Malindi, Kenya. Trans. R. Soc. Trop. Med. Hyg. 80:201-203.
30. Staedke, S. G., M. R. Kamya, G. Dorsey, A. Gasasira, G. Ndeezi, E. D. Charlebois, and P. J. Rosenthal. 2001. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 358:368-374.
31. Sweet, D. H., K. T. Bush, and S. K. Nigam. 2001. The organic anion transporter family: from physiology to ontogeny and the clinic. Am. J. Physiol. Renal Physiol. 281:F197-F205.
32. Takeda, M., S. Khamdang, S. Narikawa, H. Kimura, M. Hosoyamada, S. H. Cha, T. Sekine, and H. Endou. 2002. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J. Pharmacol. Exp. Ther. 302:666-671.
33. Terlouw, D. J., J. M. Courval, M. S. Kolczak, O. S. Rosenberg, A. J. Oloo, P. A. Kager, A. A. Lal, B. L. Nahlen, and F. O. ter Kuile. 2003. Treatment history and treatment dose are important determinants of sulfadoxine-pyrimethamine efficacy in children with uncomplicated malaria in Western Kenya. J. Infect. Dis. 187:467-476.
34. Thomas, S. M., O. Ndir, T. Dieng, S. Mboup, D. Wypij, J. H. Maguire, and D. F. Wirth. 2002. In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdrl polymorphisms in Plasmodium falciparum isolates from Senegal. Am. J. Trop. Med. Hyg. 66:474-480.
35. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
36. Trape, J. F. 2001. The public health impact of chloroquine resistance in Africa. Am. J. Trop. Med. Hyg. 64:12-17.
37. Uwai, Y., H. Saito, and K. Inui. 2000. Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter. Eur. J. Pharmacol. 409:31-36.
38. Van Dillen, J., M. Custers, A. Wensink, B. Wouters, T. van Voorthuizen, W. Voorn, B. Khan, L. Muller, and C. Nevill. 1999. A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya. Trans. R. Soc. Trop. Med. Hyg. 93:185-188.
39. Walter, R. D., B. Bergmann, M. Kansy, M. Wiese, and J. K. Seydel. 1991. Pyrimethamine-resistant Plasmodium falciparum lack cross-resistance to methotrexate and 2,4-diamino-5-(substituted benzyl) pyrimidines. Parasitol. Res. 77:346-350.
40. Wang, P., R. K. Brobey, T. Horii, P. F. Sims, and J. E. Hyde. 1999. Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy. Mol. Microbiol. 32:1254-1262.
41. Watkins, W. M., E. K. Mberu, P. A. Winstanley, and C. V. Plowe. 1997. The efficacy of antifolate antimalarial combination in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitol. Today 13:459-464.
42. Watkins, W. M., D. G. Sixsmith, J. D. Chulay, and H. C. Spencer. 1985. Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. Mol. Biochem. Parasitol. 14:55-61.
43. Watkins, W. M., D. G. Sixsmith, H. C. Spencer, D. A. Boriga, D. M. Karluki, T. Kipingor, and D. K. Koech. 1984. Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet i:357-359.
44. World Health Organization. 1997. World malaria situation in 1994. Wkly. Epidemiol. Rec. 72:269-276.
45. Zhang, H., E. M. Howard, and P. D. Roepe. 2002. Analysis of the antimalarial drug resistance protein Pfcrt expressed in yeast. J. Biol. Chem. 277:49767-49775.
46. Zhang, Y., S. Merali, and S. R. Meshnick. 1992. p-Aminobenzoic acid transport by normal and Plasmodium falciparum-infected erythrocytes. Mol. Biochem. Parasitol. 52:185-194.